The immune response of Atlantic salmon, Salmo salar L., to the causative agent of bacterial kidney disease, Renibacterium salmoninarum

1981 ◽  
Vol 4 (2) ◽  
pp. 99-111 ◽  
Author(s):  
W. D. PATERSON ◽  
D. DESAUTELS ◽  
J. M. WEBER
Keyword(s):  
Immune Response ◽  
Kidney Disease ◽  
Atlantic Salmon ◽  
Salmo Salar ◽  
Causative Agent ◽  
Renibacterium Salmoninarum ◽  
Atlantic Salmon Salmo Salar ◽  
Bacterial Kidney Disease

Kidney Disease in Juvenile Atlantic Salmon (Salmo salar) in the Margaree River

1969 ◽  
Vol 26 (9) ◽  
pp. 2535-2537 ◽  
Author(s):  
J. H. C. Pippy
Keyword(s):  
Kidney Disease ◽  
Atlantic Salmon ◽  
Salmo Salar ◽  
River System ◽  
Juvenile Salmon ◽  
Wild Salmon ◽  
Atlantic Salmon Salmo Salar ◽  
Bacterial Kidney Disease ◽  
Juvenile Atlantic Salmon

Bacterial kidney disease was presumptively identified in each of 25 hatchery-reared juvenile salmon (Salmo salar) but in only 2 of 235 wild juveniles in the Margaree River system. Apparently spread of disease from the hatchery to wild salmon in the river is very gradual.

scholarly journals The Analysis of Live-Attenuated Piscirickettsia salmonis Vaccine Reveals the Short-Term Upregulation of Innate and Adaptive Immune Genes in Atlantic Salmon (Salmo salar): An In Situ Open-Sea Cages Study

2021 ◽  
Vol 9 (4) ◽  
pp. 703
Author(s):  
Deborah Vargas ◽  
Eva Vallejos-Vidal ◽  
Sebastián Reyes-Cerpa ◽  
Aarón Oyarzún-Arrau ◽  
Claudio Acuña-Castillo ◽  
...  
Keyword(s):  
Immune Response ◽  
Atlantic Salmon ◽  
Salmo Salar ◽  
Cellular Response ◽  
Short Term ◽  
Live Attenuated Vaccine ◽  
Gene Markers ◽  
Post Vaccination ◽  
Atlantic Salmon Salmo Salar ◽  
Piscirickettsia Salmonis

Piscirickettsia salmonis, the etiological agent of the Salmon Rickettsial Septicemia (SRS), is one the most serious health problems for the Chilean salmon industry. Typical antimicrobial strategies used against P. salmonis include antibiotics and vaccines, but these applications have largely failed. A few years ago, the first attenuated-live vaccine against SRS (ALPHA JECT LiVac® SRS vaccine) was released to the market. However, there is no data about the agents involved in the activation of the immune response induced under field conditions. Therefore, in this study we evaluated the expression profile of a set of gene markers related to innate and adaptive immunity in the context of a cellular response in Atlantic salmon (Salmo salar) reared under productive farm conditions and immunized with a live-attenuated vaccine against P. salmonis. We analyzed the expression at zero, 5-, 15- and 45-days post-vaccination (dpv). Our results reveal that the administration of the attenuated live SRS LiVac vaccine induces a short-term upregulation of the cellular-mediated immune response at 5 dpv modulated by the upregulation of ifnα, ifnγ, and the cd4 and cd8α T cell surface markers. In addition, we also registered the upregulation of il-10 and tgfβ. Altogether, the results suggest that a balanced activation of the immune response took place only at early times post-vaccination (5 dpv). The scope of this short-term upregulation of the cellular-mediated immune response against a natural outbreak in fish subjected to productive farm conditions deserves further research.

Sign in / Sign up

Export Citation Format

Share Document